Related Experiment Video
Updated: Jan 21, 2026

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
Published on: March 3, 2015
WWP2 regulates pathological cardiac fibrosis by modulating SMAD2 signaling
Huimei Chen1, Aida Moreno-Moral1, Francesco Pesce2
1Programme in Cardiovascular and Metabolic Disorders, Duke-NUS Medical School, Singapore, 169857, Republic of Singapore.
Abstract:
Cardiac fibrosis is a final common pathology in inherited and acquired heart diseases that causes cardiac electrical and pump failure. Here, we use systems genetics to identify a pro-fibrotic gene network in the diseased heart and show that this network is regulated by the E3 ubiquitin ligase WWP2, specifically by the WWP2-N terminal isoform. Importantly, the WWP2-regulated pro-fibrotic gene network is conserved across different cardiac diseases characterized by fibrosis: human and murine dilated cardiomyopathy and repaired tetralogy of Fallot. Transgenic mice lacking the N-terminal region of the WWP2 protein show improved cardiac function and reduced myocardial fibrosis in response to pressure overload or myocardial infarction. In primary cardiac fibroblasts, WWP2 positively regulates the expression of pro-fibrotic markers and extracellular matrix genes. TGFβ1 stimulation promotes nuclear translocation of the WWP2 isoforms containing the N-terminal region and their interaction with SMAD2. WWP2 mediates the TGFβ1-induced nucleocytoplasmic shuttling and transcriptional activity of SMAD2.
Insights
WWP2, a specific E3 ubiquitin ligase isoform, drives cardiac fibrosis by regulating a pro-fibrotic gene network. Inhibiting this WWP2 isoform improves cardiac function and reduces fibrosis in disease models.
Area of Science:
- Cardiovascular Biology
- Molecular Genetics
- Systems Genetics
Background:
- Cardiac fibrosis is a common pathology leading to heart failure in various heart diseases.
- Identifying the molecular regulators of cardiac fibrosis is crucial for therapeutic development.
Purpose of the Study:
- To identify a pro-fibrotic gene network in diseased hearts.
- To elucidate the role of the E3 ubiquitin ligase WWP2 in regulating this network and cardiac fibrosis.
Main Methods:
- Systems genetics approach to identify gene networks.
- Utilized transgenic mouse models (cardiac-specific WWP2 N-terminal deletion).
- In vitro studies using primary cardiac fibroblasts and TGFβ1 stimulation.
Main Results:
- Identified a conserved pro-fibrotic gene network regulated by WWP2, specifically its N-terminal isoform.
- WWP2 positively regulates pro-fibrotic markers and extracellular matrix genes in cardiac fibroblasts.
- WWP2 mediates TGFβ1-induced SMAD2 nuclear translocation and transcriptional activity, promoting fibrosis.
Conclusions:
- The WWP2 N-terminal isoform is a key regulator of cardiac fibrosis across diverse heart conditions.
- Targeting WWP2 offers a potential therapeutic strategy to mitigate cardiac fibrosis and improve cardiac function.
Related Concept Videos
GTPases and their Regulation
Large G-proteins,...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Bacterial Signaling
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
What is Cell Signaling?
Epigenetic Regulation

